Epigenetic changes in insulin target organs can be reflected in blood, DNA methylation in blood may be related to the occurrence of T2DM, and related differentially methylated genes can be used as potential candidate biomarkers of T2DM (89, 90). This evidence concerns the gene INS and type 2 diabetes mellitus.